Literature DB >> 18387688

Liver regeneration and recanalization time course following reversible portal vein embolization.

Panagiotis Lainas1, Lyes Boudechiche, Angel Osorio, Aurore Coulomb, Anne Weber, Danièle Pariente, Dominique Franco, Ibrahim Dagher.   

Abstract

BACKGROUND/AIMS: Permanent portal vein embolization (PVE) is a widely practised technique. The use of an absorbable material would be safer in clinical situations in which the embolized liver is not resected. We evaluated the efficiency of reversible PVE in terms of liver regeneration and analyzed the precise time course of portal recanalization.
METHODS: Nine monkeys underwent PVE of the left and right anterior portal branches using powdered absorbable material. Repeated portograms were carried out until complete revascularization of the embolized liver. Hepatocyte proliferation rates were assessed by BrdU incorporation. Liver segment volumes were determined by CT scans performed before embolization, then 1 month and 1 year after embolization.
RESULTS: Reversible PVE induced significant hepatocyte proliferation in the non-embolized segments (13.5+/-1.0%, 10.5+/-0.8% and 9.1+/-2.0% of cells on days 3, 5 and 7, respectively). One month after the embolization, the non-embolized liver volume had increased from 38.4+/-1.3% to 54.8+/-0.5% of total liver volume. Proximal and complete revascularization occurred 6-8 and 12-16 days, respectively.
CONCLUSIONS: Reversible PVE efficiently induces liver regeneration. The use of absorbable material avoids long-term liver scarring. Such material may be suitable for several clinical indications, including cell transplantation.

Mesh:

Year:  2008        PMID: 18387688     DOI: 10.1016/j.jhep.2008.01.034

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  13 in total

Review 1.  Hepatocyte Transplantation: Quo Vadis?

Authors:  Mark Barahman; Patrik Asp; Namita Roy-Chowdhury; Milan Kinkhabwala; Jayanta Roy-Chowdhury; Rafi Kabarriti; Chandan Guha
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-11-29       Impact factor: 7.038

2.  Chronological changes in the liver after temporary partial portal venous occlusion.

Authors:  Koji Hamasaki; Susumu Eguchi; Akihiko Soyama; Masaaki Hidaka; Mitsuhisa Takatsuki; Fumihiko Fujita; Kengo Kanetaka; Shigeki Minami; Tamotsu Kuroki
Journal:  World J Gastroenterol       Date:  2013-09-14       Impact factor: 5.742

Review 3.  Human hepatocyte transplantation: current experience and future challenges.

Authors:  Anil Dhawan; Juliana Puppi; Robin D Hughes; Ragai R Mitry
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-04-06       Impact factor: 46.802

4.  Transplantation of hepatocytes from genetically engineered pigs into baboons.

Authors:  Hayato Iwase; Hong Liu; Eva Schmelzer; Mohamed Ezzelarab; Martin Wijkstrom; Hidetaka Hara; Whayoung Lee; Jagjit Singh; Cassandra Long; Eric Lagasse; Jörg C Gerlach; David K C Cooper; Bruno Gridelli
Journal:  Xenotransplantation       Date:  2017-01-28       Impact factor: 3.907

5.  Improved Hepatocyte Engraftment After Portal Vein Occlusion in LDL Receptor-Deficient WHHL Rabbits and Lentiviral-Mediated Phenotypic Correction In Vitro.

Authors:  Sylvie Goulinet-Mainot; Hadrien Tranchart; Marie-Thérèse Groyer-Picard; Panagiotis Lainas; Papa Saloum Diop; Delphine Holopherne; Patrick Gonin; Karim Benihoud; Nathalie Ba; Olivier Gauthier; Dominique Franco; Catherine Guettier; Danièle Pariente; Anne Weber; Ibrahim Dagher; Tuan Huy Nguyen
Journal:  Cell Med       Date:  2012-05-08

6.  Patch grafting, strategies for transplantation of organoids into solid organs such as liver.

Authors:  Wencheng Zhang; Giacomo Lanzoni; Homayoun Hani; Diletta Overi; Vincenzo Cardinale; Sean Simpson; Wendy Pitman; Amanda Allen; Xianwen Yi; Xicheng Wang; David Gerber; Glenn Prestwich; Oswaldo Lozoya; Eugenio Gaudio; Domenico Alvaro; Debra Tokaz; Juan Dominguez-Bendala; Christopher Adin; Jorge Piedrahita; Kyle Mathews; Praveen Sethupathy; Guido Carpino; Zhiying He; Eliane Wauthier; Lola M Reid
Journal:  Biomaterials       Date:  2021-08-25       Impact factor: 12.479

7.  Is Portal Vein Embolization Followed by Hepatectomy for Hepatocellular Carcinoma Justified in Patients with Impaired Liver Function?

Authors:  Katsunori Imai; Yo-Ichi Yamashita; Yosuke Nakao; Takashi Matsumoto; Shotaro Kinoshita; Toshihiko Yusa; Yuki Kitano; Takayoshi Kaida; Hiromitsu Hayashi; Hideo Baba
Journal:  Ann Surg Oncol       Date:  2020-08-01       Impact factor: 5.344

8.  Improved liver function after portal vein embolization and an elective right hepatectomy.

Authors:  Raphael P H Meier; Christian Toso; Sylvain Terraz; Romain Breguet; Thierry Berney; Axel Andres; Anne-Sophie Jannot; Laura Rubbia-Brandt; Philippe Morel; Pietro E Majno
Journal:  HPB (Oxford)       Date:  2015-09-08       Impact factor: 3.647

9.  Liver related complications in unresectable disease after portal vein embolization.

Authors:  Floor Huisman; Kasia P Cieslak; Krijn P van Lienden; Roelof J Bennink; Thomas M van Gulik
Journal:  Hepatobiliary Surg Nutr       Date:  2017-12       Impact factor: 7.293

Review 10.  Human pluripotent stem cells for modelling human liver diseases and cell therapy.

Authors:  Noushin Dianat; Clara Steichen; Ludovic Vallier; Anne Weber; Anne Dubart-Kupperschmitt
Journal:  Curr Gene Ther       Date:  2013-04       Impact factor: 4.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.